Last reviewed · How we verify

NCT05472987: ROVHR

Robotic Versus Open Ventral Hernia Repair

Recruiting now NA Last updated 7 October 2025
What this trial tests

NA trial testing Ventral Hernia Repair in Ventral Hernia in 200 participants. Currently enrolling.

Timeline
25 July 2022
Primary endpoint
1 August 2027
1 August 2027

Quick facts

Lead sponsorLucas Beffa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment200
Start date25 July 2022
Primary completion1 August 2027
Estimated completion1 August 2027
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Lucas Beffa

Who can join

18 and older, any sex, with Ventral Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Robotic versus open ventral hernia repair (ROVHR): a randomized controlled trial protocol.
    Carvalho AC, Woo KP, Ellis RC, Tu C, et al · · 2025 · cited 2× · PMID 40035894 · DOI 10.1007/s10029-025-03299-7

Verify or expand the search:

Other trials of Ventral Hernia Repair

Trials testing the same drug.

Other recruiting trials for Ventral Hernia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05472987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing